3.55
Sight Sciences Inc Aktie (SGHT) Neueste Nachrichten
Affiliate notice: SGHT (NASDAQ: SGHT) proposes common-share sale tied to vesting - stocktitan.net
SGHT (NASDAQ: SGHT) sale notice: 13,761 restricted shares vesting - stocktitan.net
Sight Sciences wins $34M patent ruling against Alcon - MSN
Published on: 2026-04-05 14:40:16 - baoquankhu1.vn
SGHT SEC FilingsSight Sciences, Inc. 10-K, 10-Q, 8-K Forms - stocktitan.net
Insider Selling: Sight Sciences (NASDAQ:SGHT) CTO Sells 8,168 Shares of Stock - MarketBeat
Taylor, EVP, operations & R&D, sells $10.6k in Sight Sciences (SGHT) By Investing.com - Investing.com South Africa
Sight Sciences (NASDAQ:SGHT) EVP Brenton Taylor Sells 2,869 Shares - marketbeat.com
Sight Sciences (NASDAQ:SGHT) CEO Sells 29,244 Shares - marketbeat.com
Taylor, EVP, operations & R&D, sells $10.6k in Sight Sciences (SGHT) - Investing.com Australia
Sight Sciences CEO Badawi sells $108k in shares By Investing.com - Investing.com India
[Form 4] Sight Sciences, Inc. Insider Trading Activity - Stock Titan
Sight Sciences CEO Badawi sells $108k in shares - Investing.com
Sight Sciences (SGHT) CTO tax-related sale of 8,168 shares disclosed - stocktitan.net
Sight Sciences (SGHT) EVP Brenton sells 2,869 shares for RSU tax obligations - stocktitan.net
Sight Sciences executive plans $90K stock sale - National Today
Alison Bauerlein plans sale of 25,874 shares (SGHT) - stocktitan.net
Insider sale notice: SGHT (NASDAQ: SGHT) 8,168 restricted shares - stocktitan.net
SGHT PE Ratio & Valuation, Is SGHT Overvalued - Intellectia AI
Sight Sciences’ Interventional Technologies for Glaucoma and Dry Eye Disease to be Featured in Multiple Clinical Presentations at the 2026 American Society of Cataract and Refractive Surgery (ASCRS) Annual Meeting - The Manila Times
New dry eye data vs. Restasis joins Sight Sciences glaucoma studies at ASCRS - stocktitan.net
SGHT (NASDAQ: SGHT) files Form 144 to sell 29,244 vested shares - stocktitan.net
Proposed share sales at SGHT (NASDAQ: SGHT) include 2,293 and 576 shares - stocktitan.net
Aug Rallies: Is Sight Sciences Inc a top pick in the sectorTrade Risk Summary & Target Return Focused Stock Picks - baoquankhu1.vn
Sight Sciences wins $34M in Alcon patent case, ongoing royalty By Investing.com - Investing.com South Africa
Sight Sciences wins $34M in Alcon patent case, ongoing royalty - Investing.com Australia
Sight Sciences to Present at the 25th Annual Needham Healthcare Conference on April 13th - Yahoo Finance
Del. Judge Upholds $34M Verdict In Glaucoma Patent Feud - Law360
Lake Street Maintains Sight Sciences(SGHT.US) With Buy Rating, Maintains Target Price $12 - Moomoo
Published on: 2026-03-31 02:42:17 - baoquankhu1.vn
Sight Sciences Wins $34 Million Patent Infringement Case Against Alcon, Secures Ongoing Royalties Through 2028 - Minichart
Sight Sciences U.S. district court issued order on post-trial motions in patent infringement case against Alcon originally filed on Sep 16, 2021 - marketscreener.com
Sight Sciences U.S. District Court Issued Order On Post-Trial Motions In Patent Infringement Case Against Alcon Originally Filed On Sep 16, 2021 - TradingView
Sight Sciences Wins Infringement Lawsuit Against Alcon - National Today
Sight Sciences Wins Key Patent Ruling in Glaucoma Case - TipRanks
Sight Sciences (NASDAQ: SGHT) awarded $34M plus 10% Hydrus royalties - stocktitan.net
Sight Sciences Secures Order on Post-Trial Motions That Preserves the Jury’s Verdict and Awards Monetary Damages to Sight Sciences Against Alcon and its Hydrus® Microstent - MarketScreener
Growth Value: Is Sight Sciences Inc on track to beat earnings2026 Movers & Fast Gain Stock Trading Tips - baoquankhu1.vn
Sight Sciences, Inc. (NASDAQ:SGHT) Receives Consensus Recommendation of "Hold" from Brokerages - marketbeat.com
Aug Ideas: Is Sight Sciences Inc in a consolidation phase2026 Highlights & High Accuracy Investment Signals - baoquankhu1.vn
Sight Sciences Inc stock faces pressure amid weak Q4 guidance and slowing growth in eye care devices - AD HOC NEWS
Citigroup maintains Sight Sciences (SGHT) neutral recommendation - MSN
Sight Sciences outlines $82M–$88M 2026 revenue target while expanding interventional dry eye strategy - MSN
Can Sight Sciences Inc weather a recession2026 Technical Overview & Weekly High Conviction Trade Ideas - baoquankhu1.vn
Earnings call transcript: Sight Sciences beats Q4 2025 forecasts, stock rises - Investing.com Nigeria
Prosight Management LP Sells 431,746 Shares of Sight Sciences, Inc. $SGHT - MarketBeat
Morgan Stanley Sticks to Its Hold Rating for Sight Sciences (SGHT) - The Globe and Mail
Sight Sciences (SGHT) Q4 2025 Earnings Transcript - AOL.com
Sight Sciences, Inc. (NASDAQ:SGHT) Q4 2025 earnings call transcript - MSN
Sight Sciences Earnings Call Highlights Disciplined Growth - TipRanks
Stock Report: Can Sight Sciences Inc weather a recession2025 Volume Leaders & Low Volatility Stock Suggestions - baoquankhu1.vn
Sight Sciences, Inc. (SGHT) reports Q4 loss, beats revenue estimates - MSN
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):